Clinical trial
Efficacy of G-CSF-Priming in Elderly AML Patients
NCT00199147 · Johann Wolfgang Goethe University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00199147 |
|---|---|
| Title | Efficacy of G-CSF-Priming in Elderly AML Patients |
| Official title | Treatment of Elderly Patients (>60 Years) With Acute Myeloblastic Leukemia or Advanced MDS (RAEB-T): An Open Randomized Study to Test the Efficacy of G-CSF-Priming and a Feasibility Trial of Dose-Reduced Allogeneic Transplantation and of Autologous Stem Cell Transplantation |
| Lead sponsor | Johann Wolfgang Goethe University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia |
| Intervention type | Drug, Procedure |
| Interventions | Cytarabine, Etoposide, Idarubicin, G-CSF, Fludarabine, Stem cell apheresis, Stem cell transplantation |
| Enrollment | 250 |
| Start date | Jan 1, 2000 |
| First posted | Sep 20, 2005 |
| Last update posted | Oct 26, 2005 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: